Cervical Cancer

Definition

The number of cervical screening tests for any reasons, including self-collection tests, conducted in Victoria from Jan 2018 to Dec 2024 among women aged 25-74.

Interpretation

Cervical screening numbers measure the number of cervical screening tests in Victoria in 2024. This is a count of tests, not a count of women. Therefore, cervical screening numbers should not be directly compared with cervical coverage as coverage is calculated using the number of unique women who have completed a cervical screening test within a 5-year reporting period.

Looking at the various geographic stratifications for the total cervical screening volumes, both LPHUs and PHNs were closely aligned with population sizes, with larger populations corresponding to higher screening volumes whereas, smaller populations were associated with lower screening volumes.

The increased test volumes in 2024 correspond to the majority of participants screened on time in 2018 and 2019 being due for their next round of screening under the five-yearly screening interval introduced in 2017.

Cervical Screening & Self-collection in Victoria (Jan 2018 - Dec 2024)

1. Definition:

Number of cervical screening tests, including self-collection tests, conducted in Victoria from Jan 2018 to Dec 2024 among women aged 25-74. This is not a count of women.

'Self-collection % among HPV tests' uses self-collection tests as the numerator and total HPV tests as the denominator (i.e., excludes cytology tests).

'Total CSTs' includes both HPV and cytology tests. 

2. Data sources:

NCSR Raw Data Extract - released July 2025 - for period Jan 2023 - Dec 2024

NCSR Raw Data Extract - released November 2024 - for period Jan 2018 - Dec 2022

3. Self-collection data is only available from 2022 onwards.

 The eligibility criteria for access to self-collection under the NCSR Self-collection policy was changed from 1 July 2022. The change allows self-collection services to all women and people with a cervix under the NCSR, and self-collection is no longer restricted to under-screened or never-screened women.

4. Process for calculating the data:

a) Join the HPV Cytology Data Items and Person tables from the RDE using Registry Reference Number as a key.

b) Filter tests for the period of analysis (date of procedure).

c) Calculate age at the time of the episode using the difference in years between the date of birth and the date of procedure.

d) Filter tests of participants with an age at test between the ages of 25-74.

e) Filter for participants who have completed a HPV test.

f) Filter self-collection from HPVTestCollectionMethod variable (1 = Practitioner-collected sample, 2 = Self-collection sample, and unknown or not recorded).

g) Allocate a postcode at the time of the episode. Join dataset with Address link table using HPVCytologyID as a key. Then link the outcome with Address table using Address ID as a key.

h) Reallocate some postcodes based on the address details (for instance, PO boxes were allocated to the suburb of the address).

i) Include only Victorian postcodes

5. Please note that CSTs of a subset of women who are currently participating in the Compass trial are not included in the NCSR RDE.

Data for batches of Compass women who have completed their trial participation commenced transfer to NCSR from August 2022. Fluctuation in historical screening data may be seen due as this data is periodically ingested into the RDE.

The Compass trial is a clinical trial comparing two and a half-yearly Pap test screening with five yearly HPV DNA screening.

The Compass pilot study commenced recruitment in October 2013 and the Main trial commenced recruitment in January 2015.

http://www.compasstrial.org.au/

6. The following grouping of screening history category was used for self-collection numbers:

a) To obtain previous CSTs for screening history stratification, join dataset with MigrationCytology table (keeping all rows in Migration Cytology) and use Register Reference Number as the key.

b) Calculate the number of days between the pre-renewal test (Migration Cytology) and HPV test as the difference in days between TestDate and DateOfProcedure.

c) Select the most recent migration test prior to the test in the period of interest.

d) Join dataset with the entire HPVCytologyDataItems table using Register Reference Number as the key to obtain CSTs prior tests in the period of interest.

e) Calculate the number of days between tests in the entire HPVCytologyDataItems table and the tests in the period of interest.

f) Select the most recent test prior to the test in the period of interest.

• Under-screened women are defined as those who have had a previous recorded test and were 2 or more years overdue for screening prior to the test of interest.
• Never-screened women are defined as those who had no recorded tests prior to the test of interest.
• On-time women are defined as those who have had a previous recorded test and were less than 2 years overdue for screening prior to the test of interest. In addition, all women aged under 27 are classified as "On-time."

7. Geocoding and validation of addresses were completed using the Experian Address Validation tool, using the Australia Post Postal Address File as the reference dataset.

8. The Local Government Area (LGA) data in this report was derived using the following methods:

• For street addresses where the Experian Address Validation result indicated a high-quality match and Local Government Area (LGA) was populated by Experian, that LGA data is presented in this report.  
• For addresses which had a low-quality match, could not be matched, were PO Boxes or were missing LGA from Experian, postcode was converted to LGA based on the following concordances:  

ASGS Geographic Correspondences Table 3 of file named CG_POSTCODE_2024_LGA_2024, which is a 2016 Mesh Block population weighted correspondence file.

Source: www.data.gov.au

Search for: ABS ASGS Correspondences

Click on: ASGS Geographic Correspondences (2021) Edition 3

Download: ASGS Edition 3 (2021) Correspondence Files (ZIP)

File name: CG_POSTCODE_2024_LGA_2024

Postcodes not listed in concordances were mapped manually to allow application of ABS concordances.

• Participants with Victorian postcodes mapped to LGAs outside Victoria were excluded from LGA and LPHU tables and therefore overall totals will not align with state totals.

9. The Moreland City Council was renamed Merri-bek City Council (LGA code: 24700) on 26 September 2022.

10. To convert data from Local Government Area (LGA) to Local Public Health Unit (LPHU), we used the mapping document provided by the Victorian Department of Health.

11. During the COVID-19 pandemic, local public health units (LPHUs) were created to oversee local cases and outbreaks of COVID-19.

As of July 2022, the nine LPHUs (three metropolitan and six regional) have expanded their roles to include disease prevention, population health, and the investigation and response to notifiable conditions.

They are now tasked with managing local cases and outbreaks for more than 30 notifiable conditions.

Metropolitan LPHUs include: North Eastern Public Health Unit, South East Public Health Unit, Western Public Health Unit

Regional LPHUs include: Barwon South West, Goulburn Valley, Gippsland, Grampians, Ovens Murray, Loddon Mallee

12. The Primary Health Network (PHN) data in this report was derived using the following methods:

• For street addresses where the Experian Address Validation result indicated a high-quality match and longitude, and latitude were populated by Experian, longitude, and latitude were converted to Statistical Area 1 (SA1) based on the following ABS shapefile:

Source: https://www.abs.gov.au/statistics/standards/australian-statistical-geography-standard-asgs-edition-3/jul2021-jun2026/access-and-downloads/digital-boundary-files

Download: Statistical Areas Level 1 - 2021 - Shapefile

File name: SA1_2021_AUST_GDA2020.shp

SA1 was then converted to PHN based on the following concordances:

Primary Health Networks (PHN) (2023) – Statistical Area Level 1 (2021)

Source: www.data.gov.au

Search for: Primary Health Networks (PHN) concordance files

Click on: Primary Health Networks (PHN) concordance files

Download: Primary Health Networks (PHN) (2023) – Statistical Area Level 1 (2021)

• For addresses which had a low-quality match, could not be matched, were PO Boxes or were missing longitude and latitude from Experian, postcode was converted to PHN based on the following concordances:  

Primary Health Networks (PHN) (2023) – Postal Areas (2021)

Source: www.data.gov.au

Search for: Primary Health Networks (PHN) concordance files

Click on: Primary Health Networks (PHN) concordance files

Download: Primary Health Networks (PHN) (2023) – Postal Areas (2021)

Postcodes not listed in concordances were mapped manually to allow application of ABS concordances.

• Please note that due to rounding, overall total may not align with state totals.

13. Primary Health Networks (PHNs) are independent organisations that are funded by the Australian Government to oversee primary health care in their respective regions.

PHNs evaluate the health needs of their communities and commission services to ensure that individuals can access coordinated care when and where it's needed.

There are 6 Primary Health Network (PHN) regions in Victoria. 

Metropolitan PHNs include: Eastern Melbourne, North Western Melbourne, South Eastern Melbourne

Regional PHNs include: Gippsland, Murray, Western Victoria

14. Cells with a count less than 5 have been suppressed, and are represented by #

To ensure the suppressed value cannot be determined by other values in the row or column, or by the row or column total, other values in the row or column may also be suppressed.

15. Rounding of cells has been applied to enable cell suppression. As a result, a table with more than one level of stratification may not exactly match the totals in the previous stratification level table."

16. Please note that the COVID-19 pandemic impacted screening services and health seeking behaviours which will be reflected in the data in 2020-2022.

17. Please note throughout this report we generally use the term ‘women’ to refer to people eligible for or attending cervical screening. However, we respectfully acknowledge that some people with a cervix do not identify as women and are equally impacted by the risk of cervical cancer. Currently only sex at birth can be provided in this report.

Definition

The number of self-collected cervical screening tests performed by eligible people aged 25-74 over a 12-month period.

The uptake of self-collection tests is the percentage of self-collection tests among all HPV tests performed by year.

“On-time” refers to eligible people who were less than two years overdue for screening (less than four years since last Pap screening test or less than 7 years since last HPV screening test).

“Under screened” refers to eligible people who were more than 2 years overdue for screening.

“Never screened” refers to eligible people who had no prior cervical screening tests.  

Interpretation

Prior to 1 July 2022, HPV self-collection in Australia was restricted to people aged 30 or older who were either under-screened (two or more years overdue for screening) or had never been screened. As of 1 July 2022, all women and people with a cervix have to access self-collection under the National Cervical Screening Program. Among all HPV tests, self-collection uptake was highest in the older age groups, with the 70–74 age group recording 44.37%.

The highest uptake of self-collection tests by screening history among all HPV tests was observed in the under-screened (50.85%) and never-screened people (43.60%) compared with people who screen on-time (32.97%).

This suggests that self-collection has been effective at reducing barriers to accessing cervical screening among under-screened and never-screened populations.

In terms of geographical uptake of self-collection, regional LPHUs observed a higher uptake of self-collected HPV testing compared to metropolitan LPHUs. In three regional LPHUs, over half of HPV tests were self-collected.

Cervical Screening & Self-collection in Victoria (Jan 2018 - Dec 2023)

1. Definition:

Number of cervical screening tests, including self-collection tests, conducted in Victoria from Jan 2018 to Dec 2023 among women aged 25-74. This is not a count of women.

'Self-collection % among HPV tests' uses self-collection tests as the numerator and total HPV tests as the denominator (i.e., excludes cytology tests).

'Total CSTs' includes both HPV and cytology tests. 

2. Data sources:

NCSR Raw Data Extract - released November 2024 - for period Jan 2018 - Dec 2023

3. Self-collection data is only available from 2022 onwards.

The eligibility criteria for access to self-collection under the NCSR Self-collection policy was changed from 1 July 2022. The change allows self-collection services to all women and people with a cervix under the NCSR, and self-collection is no longer restricted to under-screened or never-screened women.

4. Process for calculating the data:

a) Join the HPV Cytology Data Items and Person tables from the RDE using Registry Reference Number as a key.

b) Filter tests for the period of analysis (date of procedure).

c) Calculate age at the time of the episode using the difference in years between the date of birth and the date of procedure.

d) Filter tests of participants with an age at test between the ages of 25-74.

e) Filter for participants who have completed a HPV test.

f) Filter self-collection from HPVTestCollectionMethod variable (1 = Practitioner-collected sample, 2 = Self-collection sample, and unknown or not recorded).

g) Allocate a postcode at the time of the episode. Join dataset with Address link table using HPVCytologyID as a key. Then link the outcome with Address table using Address ID as a key.

h) Reallocate some postcodes based on the address details (for instance, PO boxes were allocated to the suburb of the address).

i) Include only Victorian postcodes

5. Please note that self-collection percentages are among HPV tests only. Self-collection was determined from the HPVTestCollectionMethod variable (1 = Practitioner-collected sample, 2 = Self-collection sample, and unknown or not recorded).

6. Please note that CSTs of a subset of women who are currently participating in the Compass trial are not included in the NCSR RDE.

Data for batches of Compass women who have completed their trial participation commenced transfer to NCSR from August 2022. Fluctuation in historical screening data may be seen due as this data is periodically ingested into the RDE.

The Compass trial is a clinical trial comparing two and a half-yearly Pap test screening with five yearly HPV DNA screening. The Compass pilot study commenced recruitment in October 2013 and the Main trial commenced recruitment in January 2015 (http://www.compasstrial.org.au/).

7. The following grouping of screening history category was used for self-collection numbers:

a) To obtain previous CSTs for screening history stratification, join dataset with MigrationCytology table (keeping all rows in Migration Cytology) and use Register Reference Number as the key.

b) Calculate the number of days between the pre-renewal test (Migration Cytology) and HPV test as the difference in days between TestDate and DateOfProcedure.

c) Select the most recent migration test prior to the test in the period of interest.

d) Join dataset with the entire HPVCytologyDataItems table using Register Reference Number as the key to obtain CSTs prior tests in the period of interest.

e) Calculate the number of days between tests in the entire HPVCytologyDataItems table and the tests in the period of interest.

f) Select the most recent test prior to the test in the period of interest.

• Under-screened women are defined as those who have had a previous recorded test and were 2 or more years overdue for screening prior to the test of interest.
• Never-screened women are defined as those who had no recorded tests prior to the test of interest.
• On-time women are defined as those who have had a previous recorded test and were less than 2 years overdue for screening prior to the test of interest. In addition, all women aged under 27 are classified as "On-time."

8.Geocoding and validation of addresses were completed using the Experian Address Validation tool, using the Australia Post Postal Address File as the reference dataset.

9. The Local Government Area (LGA) data in this report was derived using the following methods:

• For street addresses where the Experian Address Validation result indicated a high-quality match and Local Government Area (LGA) was populated by Experian, that LGA data is presented in this report.  
• For addresses which had a low-quality match, could not be matched, were PO Boxes or were missing LGA from Experian, postcode was converted to LGA based on the following concordances:  

ASGS Geographic Correspondences Table 3 of file named CG_POSTCODE_2022_LGA_2022, which is a 2016 Mesh Block population weighted correspondence file.

Source: www.data.gov.au

Search for: ABS ASGS Correspondences

Click on: ASGS Geographic Correspondences (2021) Edition 3

Download: ASGS Edition 3 (2021) Correspondence Files (ZIP)

File name: CG_POSTCODE_2022_LGA_2022

Postcodes not listed in concordances were mapped manually to allow application of ABS concordances.

• Participants with Victorian postcodes mapped to LGAs outside Victoria were excluded from LGA and LPHU tables and therefore overall totals will not align with state totals.

10. To convert data from Local Government Area (LGA) to Local Public Health Unit (LPHU), we used the mapping document provided by the Department of Health.

11. During the COVID-19 pandemic, local public health units (LPHUs) were created to oversee local cases and outbreaks of COVID-19. As of July 2022, the nine LPHUs (three metropolitan and six regional) have expanded their roles to include disease prevention, population health, and the investigation and response to notifiable conditions. They are now tasked with managing local cases and outbreaks for more than 30 notifiable conditions.

• Metropolitan LPHUs: North Eastern Public Health Unit, South East Public Health Unit, Western Public Health Unit
• Regional LPHUs: Barwon South West, Goulburn Valley, Gippsland, Grampians, Ovens Murray, Loddon Mallee

12. The Primary Health Network (PHN) data in this report was derived using the following methods:

• For street addresses where the Experian Address Validation result indicated a high-quality match and longitude, and latitude were populated by Experian, longitude, and latitude were converted to Statistical Area 1 (SA1) based on the following ABS shapefile:

Source: https://www.abs.gov.au/statistics/standards/australian-statistical-geography-standard-asgs-edition-3/jul2021-jun2026/access-and-downloads/digital-boundary-files

Download: Statistical Areas Level 1 - 2021 - Shapefile

File name: SA1_2021_AUST_GDA2020.shp

SA1 was then converted to PHN based on the following concordances:

Primary Health Networks (PHN) (2023) – Statistical Area Level 1 (2021)

Source: www.data.gov.au

Search for: Primary Health Networks (PHN) concordance files

Click on: Primary Health Networks (PHN) concordance files

Download: Primary Health Networks (PHN) (2023) – Statistical Area Level 1 (2021)

• For addresses which had a low-quality match, could not be matched, were PO Boxes or were missing longitude and latitude from Experian, postcode was converted to PHN based on the following concordances:  

Primary Health Networks (PHN) (2023) – Postal Areas (2021)

Source: www.data.gov.au

Search for: Primary Health Networks (PHN) concordance files

Click on: Primary Health Networks (PHN) concordance files

Download: Primary Health Networks (PHN) (2023) – Postal Areas (2021)

Postcodes not listed in concordances were mapped manually to allow application of ABS concordances.

• Please note that due to rounding, overall total may not align with state totals.

13. Primary Health Networks (PHNs) are independent organisations that are funded by the Australian Government to oversee primary health care in their respective regions. PHNs evaluate the health needs of their communities and commission services to ensure that individuals can access coordinated care when and where it's needed. There are 6 Primary Health Network (PHN) regions in Victoria. 

• Metropolitan PHNs: Eastern Melbourne, North Western Melbourne, South Eastern Melbourne
• Regional PHNs: Gippsland, Murray, Western Victoria

14. Cells with a count less than 5 have been suppressed and are represented by #.

To ensure the suppressed value cannot be determined by other values in the row or column, or by the row or column total, other values in the row or column may also be suppressed.

15. Rounding of cells has been applied to enable cell suppression. As a result, a table with more than one level of stratification may not exactly match the totals in the previous stratification level table.

16. Please note that the COVID-19 pandemic impacted screening services and health seeking behaviours which will be reflected in the data in 2020-2022.

17. Please note throughout this report we generally use the term ‘women’ to refer to people eligible for or attending cervical screening. However, we respectfully acknowledge that some people with a cervix do not identify as women and are equally impacted by the risk of cervical cancer. Currently only sex at birth can be provided in this report.

Time to Colposcopy (Jan 2018 - Dec 2024)

1. Definition:

Time to colposcopy is the number of days between the date of Cervical Screening Tests (CSTs) and the date of the first subsequent colposcopy.

 % is calculated by:

• Numerator: Number of women (with Victorian residential addresses at the time of the episode) who received a cervical screening test result in a calendar year which places them at higher risk of cervical abnormality within the next five years, and who completed a colposcopy.
• Denominator: Number of women (with Victorian addresses at the time of the episode) who received a cervical screening test result in a calendar year which places them at higher risk of cervical abnormality within the next five years.

Note: Sex, not identified gender, is presented in this report. Sex is provided by Medicare.

2. Data source:

NCSR Raw Data Extract (RDE) released Jul 2025 - for 2023 to 2024 data

NCSR Raw Data Extract (RDE) released Feb 2025 - for 2018 to 2022 data

3. This report contains colposcopy procedures identified from the following tables in the NCSR RDE:

i) ColposcopyDataItems

ii) HistologyDataItems

Histology episodes were counted as colposcopy under the assumption that the woman had her cervix visualised during that episode to obtain the biopsy.

4. The data presented in calendar years is based on the date of CSTs.

The date of colposcopy or histopathology was not restricted. However, some women in the "No colposcopy" category may have had colposcopy after data extraction.

5. Time to colposcopy was calculated as the number of days between the date of CST and the first date of colposcopy (or date of histopathology).

"Colposcopy or histology episodes occurring between 1 to 5 days before the CST date were considered as valid colposcopies, as were episodes that were on or after the CST date."

These breakdowns were used:

• By 3 months
• By 6 months
• By 12 months
• Ever attended

6. Age at the time of the episode was calculated as the number of years between the Date of Birth and the Date of CST and was restricted to 25-74 years old at the time of the CST.

7. This analysis only includes women residents in Victoria at the time of the episode. Women with no postcode recorded at the time of the episode or women with an interstate postcode were excluded from the data.

8. The following grouping was used for HPV test results:

9. The following abbreviations are used for liquid-based cytology (LBC) results: 

10. Updates to the Clinical Guidelines came into effect from 1 February 2021 for women with a follow-up test result of HPV not 16/18 who were negative/pLSIL/LSIL on LBC. 

Prior to this date, these women were referred for colposcopy. From this date, these women are recommended to undertake a second HPV test in 12 months, except for the following groups of women who are recommended direct referral to colposcopy:

• Women aged 50+ years
• Aboriginal or Torres Strait Islander women
• Women overdue for screening by at least 2 years at initial screen

These direct referrals from 1 February 2021 are not included in these data tables. Therefore, there are some women who were managed as higher risk but are not presented in this data. 

11. The higher risk test result categories are as follows:

• Primary screening test HPV 16/18 + any LBC result
• Primary screening test HPV not 16/18 + LBC result of pHSIL/HSIL/cervical cancer/any glandular abnormality 
• First follow-up tests (prior to 1 Feb 2021): Any HPV detected
• First follow-up tests (from 1 Feb 2021): HPV 16/18 + any LBC, OR HPV not 16/18 + LBC result of pHSIL/HSIL/cervical cancer/any glandular abnormality 
• Second follow-up tests (from 1 Feb 2021): Any HPV detected

12. Women were counted only once per year (first CST of the year) irrespective of whether she had more than one CST with a higher risk result in the same year. Therefore, this report contains a count of women, not tests. 

13. If a woman had multiple higher risk test results, we looked at whether women attended for colposcopy from the date of the first higher risk result.

We counted higher risk test results according to the following rules:

a) Women that have multiple higher risk CST results and went to colposcopy only once (same colposcopy date for more than one CST date)

• If the woman had more than one higher risk CST result but only had one colposcopy, then the woman was counted only once (first referral).
• Time to colposcopy was calculated from the first time she had a CST with a higher risk result to the date of her only colposcopy. All the other higher risk CSTs were excluded from the data.

b) Women that have more than one higher risk CST result and still have not attended to colposcopy

• If the woman had multiple higher risk results but has not had a colposcopy, then the woman was counted only once on the date of the first higher risk result.

c) Women that have multiple higher risk CST results and attended colposcopy on different dates subsequent to each higher risk result.

• If the woman had multiple higher risk CST results and had a colposcopy subsequent to each CST, then the woman was included multiple times, with the earliest colposcopy on or after the date of the higher risk CST.

14. This report only includes primary and follow-up CSTs with higher risk results. Non-screening tests such as co-test (test of cure), co-test (investigation of signs or symptoms) and co-test (other, as recommended in guidelines) are not included.

15. Geocoding and validation of addresses was completed using the Experian Address Validation tool, using the Australia Post Postal Address File as the reference dataset.

16. The Local Government Area (LGA) data in this report was derived using the following methods:

• For street addresses where the Experian Address Validation result indicated a high-quality match and Local Government Area (LGA) was populated by Experian, that LGA data is presented in this report.  
• For addresses which had a low-quality match, could not be matched, were PO Boxes or were missing LGA from Experian, and addresses prior to 2021, postcode was converted to LGA based on the following concordances:  

ASGS Geographic Correspondences Table 3 of file named CG_POSTCODE_2022_LGA_2022, which is a 2016 Mesh Block population weighted correspondence file.

Source: www.data.gov.au

Search for: ABS ASGS Correspondences

Click on: ASGS Geographic Correspondences (2021) Edition 3

Download: ASGS Edition 3 (2021) Correspondence Files (ZIP)

File name: CG_POSTCODE_2022_LGA_2022

Postcodes not listed in concordances were mapped manually to allow application of ABS concordances.

• Participants with Victorian postcodes mapped to LGAs outside Victoria were excluded from LGA and LPHU tables and therefore overall totals will not align with state totals.

17. The Moreland City Council was renamed Merri-bek City Council (LGA code: 24700) on 26 September 2022.

18. To convert data from Local Government Area (LGA) to Local Public Health Unit (LPHU), we used the mapping document provided by DH.

19. The Primary Health Network (PHN) data in this report was derived using the following methods:

• For street addresses where the Experian Address Validation result indicated a high-quality match and longitude, and latitude were populated by Experian, longitude, and latitude were converted to Statistical Area 1 (SA1) based on the following ABS shapefile:

Source: https://www.abs.gov.au/statistics/standards/australian-statistical-geography-standard-asgs-edition-3/jul2021-jun2026/access-and-downloads/digital-boundary-files

Download: Statistical Areas Level 1 - 2021 - Shapefile

File name: SA1_2021_AUST_GDA2020.shp

SA1 was then converted to PHN based on the following concordances:

Primary Health Networks (PHN) (2023) – Postal Areas (2021)

Source: www.data.gov.au

Search for: Primary Health Networks (PHN) concordance files

Click on: Primary Health Networks (PHN) concordance files

Download: Primary Health Networks (PHN) (2023) – Postal Areas (2021)

• For addresses which had a low-quality match, could not be matched, were PO Boxes or were missing longitude and latitude from Experian, postcode was converted to PHN based on the following concordances:  

Primary Health Networks (PHN) (2023) – Postal Areas (2021)

Source: www.data.gov.au

Search for: Primary Health Networks (PHN) concordance files

Click on: Primary Health Networks (PHN) concordance files

Download: Primary Health Networks (PHN) (2023) – Postal Areas (2021)

Postcodes not listed in concordances were mapped manually to allow application of ABS concordances and are listed.

• Please note that due to rounding, overall total may not align with state totals.

20. Please note that the pandemic impacted screening services and health seeking behaviours which will be reflected in the data in 2020-2022.

21. Please note throughout this report we generally use the term ‘women’ to refer to people eligible for or attending cervical screening. However, we respectfully acknowledge that some people with a cervix do not identify as women and are equally impacted by the risk of cervical cancer. Currently only sex at birth can be provided in this report.